Urine Cell-Free DNA Integrity as a Marker for Early Prostate Cancer Diagnosis: A Pilot Study
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Urine Cell-Free DNA Integrity as a Marker for Early Prostate Cancer Diagnosis: A Pilot Study
Authors
Keywords
-
Journal
Biomed Research International
Volume 2013, Issue -, Pages 1-5
Publisher
Hindawi Limited
Online
2013-02-14
DOI
10.1155/2013/270457
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis
- (2017) Matelda Zancan et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
- Homozygous Deletions and Recurrent Amplifications Implicate New Genes Involved in Prostate Cancer
- (2015) Wennuan Liu et al. NEOPLASIA
- Prostate-Cancer Mortality at 11 Years of Follow-up
- (2012) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Urine Cell-Free DNA integrity as a marker for early bladder cancer diagnosis: Preliminary data
- (2012) Valentina Casadio et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis
- (2011) T Wu et al. BRITISH JOURNAL OF CANCER
- Circulating tumour markers can define patients with normal colons, benign polyps and cancers
- (2011) R Mead et al. BRITISH JOURNAL OF CANCER
- Amplification of the 20q Chromosomal Arm Occurs Early in Tumorigenic Transformation and May Initiate Cancer
- (2011) Yuval Tabach et al. PLoS One
- Serum Free Circulating DNA Is a Useful Biomarker to Distinguish Benign versus Malignant Prostate Disease
- (2010) E. Gordian et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literature
- (2010) Klaus Jung et al. CLINICA CHIMICA ACTA
- Prostate cancer screening: current status and future perspectives
- (2010) Seth A. Strope et al. Nature Reviews Urology
- Circulating mitochondrial DNA in serum: A universal diagnostic biomarker for patients with urological malignancies
- (2010) Jörg Ellinger et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
- (2009) E A M Heijnsdijk et al. BRITISH JOURNAL OF CANCER
- Screening for Prostate Cancer
- (2009) O. W. Brawley et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer
- (2009) H. Schwarzenbach et al. CLINICAL CANCER RESEARCH
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
- (2009) S. A. Bustin et al. CLINICAL CHEMISTRY
- Identification of a new prostate cancer susceptibility locus on chromosome 8q24
- (2009) Meredith Yeager et al. NATURE GENETICS
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer
- (2009) Adrian S. Ishkanian et al. PROSTATE
- Diagnostic Role of Circulating Free Plasma DNA Detection in Patients With Localized Prostate Cancer
- (2008) Annalisa Altimari et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Serum free DNA and COX-2 mRNA expression in peripheral blood for lung cancer detection
- (2008) P Ulivi et al. THORAX
- Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators
- (2007) Jörg Ellinger et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started